Apollo Global Management is in talks to acquire Johnson & Johnson’s orthopedics unit, DePuy Synthes, for around $20 billion, people familiar with the matter said. Johnson & Johnson has been seeking to divest the business, which makes hip, knee and shoulder implants, surgical instruments and other products. The company said last year that it planned to separate DePuy Synthes into a standalone business within 18 to 24 months as it focuses on higher-growth healthcare segments. The unit generated $9.3 billion in sales in 2025. The discussions may not result in a transaction, and another bidder could emerge. Bloomberg News previously reported that several private-equity firms were interested and that an agreement could be reached within weeks. Reuters could not immediately verify the report, while Apollo and Johnson & Johnson did not immediately respond to requests for comment.